Connor, Clark & Lunn Investment Management (CC&L)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.52M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $14.8M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $347K | Sell |
|
|||||
|
2022
Q4 | $391K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $3.98M | Sell |
|
|||||
|
2020
Q4 | $30.7M | Sell |
|
|||||
|
2020
Q3 | $30.3M | Buy |
|
|||||
|
2020
Q2 | $19.8M | Buy |
|
|||||
|
2020
Q1 | $4.64M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $13.1M | Sell |
|
|||||
|
2018
Q4 | $34.1M | Buy |
|
|||||
|
2018
Q3 | $42.7M | Buy |
|
|||||
|
2018
Q2 | $46.4M | Sell |
|
|||||
|
2018
Q1 | $32.7M | Buy |
|